Last $2.27 USD
Change Today -0.03 / -1.30%
Volume 292.8K
AMRS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

amyris inc (AMRS) Snapshot

Open
$2.27
Previous Close
$2.30
Day High
$2.39
Day Low
$2.25
52 Week High
12/27/13 - $6.11
52 Week Low
12/16/14 - $2.03
Market Cap
179.5M
Average Volume 10 Days
238.2K
EPS TTM
$-1.90
Shares Outstanding
79.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMYRIS INC (AMRS)

amyris inc (AMRS) Related Businessweek News

No Related Businessweek News Found

amyris inc (AMRS) Details

Amyris, Inc., a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. It builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. The company produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products. It also provides Biofene for specialty chemical applications and transportation fuels, such as diesel. In addition, the company is involved in the development, production, and commercialization of renewable base oils, as well as additives and lubricants for the automotive, industrial, and commercial lubricants markets; and offers natural oils and aroma chemicals for the flavors and fragrances market. It has a strategic partnership with Total for the production and commercialization of diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

403 Employees
Last Reported Date: 11/7/14
Founded in 2003

amyris inc (AMRS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $550.0K
Interim Chief Financial Officer
Total Annual Compensation: $377.9K
Former Chief Business Officer
Total Annual Compensation: $311.3K
President of Research and Development
Total Annual Compensation: $358.8K
Compensation as of Fiscal Year 2013.

amyris inc (AMRS) Key Developments

Amyris, Inc. Appoints Raffi Asadorian as Chief Financial Officer, Effective January 6, 2015

Amyris, Inc. announced the appointment of Raffi Asadorian as the company's Chief Financial Officer, effective January 6, 2015. The company's interim Chief Financial Officer, Paulo Diniz, will transition to a new role as Chairman of Amyris Brasil. Prior to joining Amyris, Mr. Asadorian was the Chief Financial Officer at Unilabs.

Amyris, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Revised Earnings Guidance for the Full Year of 2014

Amyris, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, total revenues were $16,341,000 against $7,004,000 a year ago. Loss from operations was $21,294,000 against $27,751,000 a year ago. Loss before income taxes was $36,538,000 against $25,663,000 a year ago. Net loss attributable to the common stockholders was $36,641,000 or $0.46 per basic and diluted share against $24,199,000 or $0.32 per basic and diluted share a year ago. Net loss attributable to common stockholders (Non-GAAP) was $22,322,000 or $0.28 per share against $20,594,000 or $0.27 per share a year ago. EBITDA (Non-GAAP) was $2,154,000 or $0.03 per share against EBITDA (Non-GAAP) of $2,671,000 or $0.04 per share a year ago. For the nine months, total revenues were $31,689,000 against $25,722,000 a year ago. Loss from operations was $72,383,000 against $94,560,000 a year ago. Loss before income taxes was $55,456,000 against $96,410,000 a year ago. Net loss attributable to the common stockholders was $55,735,000 or $0.94 per diluted share against $95,689,000 or $1.27 per basic and diluted share a year ago. Net loss attributable to common stockholders (Non-GAAP) was $70,157,000 or $0.09 per share against $66,777,000 or $0.89 per share a year ago. EBITDA (Non-GAAP) was $27,599,000 or $0.35 per share against $21,536,000 or $0.29 per share a year ago. For the full year of 2014, the company expects renewable product sales for the year to be around $30 million and collaboration inflows, a non-GAAP measure, to be around $50 million for 2014. 2014 outlook is lower than prior guidance due to timing of collaboration inflows, but in line with its longer-term outlook to double product revenues annually as well as to maintain annual collaboration inflows in the range of $60 to $70 million. The company continues to expect cash operating expenses for R&D and SG&A to be around $85 million and capital expenditures to be less than $8 million in 2014. The company expects to maintain similar levels for expenditures in the coming year. Based on the continued progress of its fragrance oils and emollient offerings, the company believe there is an opportunity to achieve positive cash flow from operations in the coming quarters.

Amyris, Inc. to Report Q3, 2014 Results on Nov 04, 2014

Amyris, Inc. announced that they will report Q3, 2014 results at 4:30 PM, US Eastern Standard Time on Nov 04, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRS:US $2.27 USD -0.03

AMRS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
American Power Group Corp $0.30 USD +0.0401
Bluefire Renewables Inc $0.05 USD -0.006
China Clean Energy Inc $0.02 USD 0.00
Gevo Inc $0.32 USD +0.0274
Solazyme Inc $2.53 USD +0.07
View Industry Companies
 

Industry Analysis

AMRS

Industry Average

Valuation AMRS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMYRIS INC, please visit www.amyris.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.